Jason Kuchar, Ph.D. strategically aligns intellectual property protection with clients’ core business objectives. His practice encompasses developing comprehensive IP strategies, including global patent prosecution, portfolio management, landscape analysis and due diligence.
Jason serves clients across the biotechnology, life sciences, pharmaceutical and chemical sectors. He advises on a wide range of cutting-edge technologies, including large and small molecule therapeutics, advanced drug delivery systems, diagnostic tools, vaccines, polypeptide and polynucleotide manufacturing, ‘omics applications (proteomics, spatialomics, metabolomics, genomics), CRISPR gene editing, analytical instrumentation and personalized medicine.